Antibodies against apoB100 peptide 210 inhibit atherosclerosis in apoE-/- mice
Abstract Atherosclerotic plaques are characterized by an accumulation and subsequent oxidation of LDL, resulting in adaptive immune responses against formed or exposed neoepitopes of the LDL particle. Autoantibodies against native p210, the 3136–3155 amino acid sequence of the LDL protein apolipopro...
Main Authors: | Pontus Dunér, Ingrid Yao Mattisson, Per Fogelstrand, Lars Glise, Stacey Ruiz, Christopher Farina, Jan Borén, Jan Nilsson, Eva Bengtsson |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-04-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-021-88430-1 |
Similar Items
-
Quantitation of apoB-48 and apoB-100 by gel scanning or radio-iodination.
by: D B Zilversmit, et al.
Published: (1989-10-01) -
Identification of autoantibodies in human plasma recognizing an apoB-100 LDL receptor binding site peptide
by: Gunilla Nordin Fredrikson, et al.
Published: (2006-09-01) -
ApoB-48 and apoB-100 differentially influence the expression of type-III hyperlipoproteinemia in APOE*2 mice
by: Myron E. Hinsdale, et al.
Published: (2002-09-01) -
Genetic control of hepatic apoB-100 secretion in human apoB transgenic mouse strains
by: Emanuel Voyiaziakis, et al.
Published: (1999-11-01) -
Chlamydia pneumoniae Infection Exacerbates Atherosclerosis in ApoB100only/LDLR−/− Mouse Strain
by: Ildikó Lantos, et al.
Published: (2018-01-01)